MEV of bupivacaine for spinal anesthesia

Not Applicable

• Conditions: Pregnancy and Childbirth; spinal anesthesia for cesarean section; Anaesthesia

• Registration Number: PACTR201609001782787
• Lead Sponsor: Faculty of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-09-16
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 120

Inclusion Criteria

we included
parturients scheduled for elective caesarean section under spinal anesthesia to one of 3 groups according to their height(ht), group 1 including those with height between 150 to 159 cm, group 2 with ht between 160 and 169 cm and group 3 patients with ht between 170 and 179 cm. All the included parturients were ASA I or II having a singleton beyond 36 weeks¿ pregnancy

Exclusion Criteria

We excluded all those with
ht below 150 or above 179 cm,
those with body mass index (BMI) above 30, with essential or pregnancy-induced hypertension, any neurological diseases, and those receiving any medications affecting the cardiovascular system.
We also excluded those with polyhydramnios, multiple gestation, having fetus with congenital anomalies
and those with any contraindication to spinal anesthesia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Minimum effective volume of bupivacaine in spinal anesthesia for elective Cesarean section for different height groups

Secondary Outcome Measures

Name	Time	Method
evel of motor and sensory block;Hemodynamic parameters